News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
445,869 Results
Type
Article (30843)
Company Profile (328)
Press Release (414692)
Multimedia
Podcasts (90)
Webinars (13)
Section
Business (119036)
Career Advice (746)
Deals (19922)
Drug Delivery (70)
Drug Development (69022)
Employer Resources (57)
FDA (10581)
Job Trends (8694)
News (216622)
Policy (18827)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (2161)
Accelerated approval (25)
Adcomms (28)
Allergies (113)
Alliances (31346)
ALS (162)
Alzheimer's disease (1626)
Antibody-drug conjugate (ADC) (311)
Approvals (10840)
Artificial intelligence (370)
Autoimmune disease (142)
Automation (22)
Bankruptcy (186)
Best Places to Work (7593)
BIOSECURE Act (8)
Biosimilars (130)
Biotechnology (245)
Bladder cancer (147)
Brain cancer (52)
Breast cancer (541)
Cancer (4208)
Cardiovascular disease (359)
Career advice (631)
Career pathing (21)
CAR-T (266)
CDC (22)
Cell therapy (673)
Cervical cancer (25)
Clinical research (58819)
Collaboration (1427)
Company closure (2)
Compensation (779)
Complete response letters (56)
COVID-19 (2127)
CRISPR (93)
C-suite (651)
Cystic fibrosis (146)
Data (5691)
Denatured (17)
Depression (120)
Diabetes (420)
Diagnostics (3664)
Digital health (24)
Diversity (5)
Diversity, equity & inclusion (20)
Drug discovery (233)
Drug pricing (86)
Drug shortages (18)
Duchenne muscular dystrophy (240)
Earnings (49420)
Editorial (34)
Employer branding (5)
Employer resources (53)
Events (73476)
Executive appointments (728)
FDA (13101)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (11)
Frontotemporal dementia (24)
Funding (1208)
Gene editing (197)
Generative AI (33)
Gene therapy (600)
GLP-1 (769)
Government (2911)
Grass and pollen (4)
Guidances (311)
Healthcare (12345)
HIV (40)
Huntington's disease (45)
IgA nephropathy (84)
Immunology and inflammation (230)
Immuno-oncology (51)
Indications (93)
Infectious disease (2325)
Inflammatory bowel disease (180)
Inflation Reduction Act (13)
Influenza (77)
Intellectual property (213)
Interviews (103)
IPO (10519)
IRA (26)
Job creations (1441)
Job search strategy (558)
JPM (49)
Kidney cancer (14)
Labor market (36)
Layoffs (343)
Leadership (17)
Legal (3122)
Liver cancer (65)
Longevity (11)
Lung cancer (566)
Lymphoma (342)
Machine learning (33)
Management (18)
Manufacturing (515)
MASH (175)
Medical device (6606)
Medtech (6637)
Mergers & acquisitions (10183)
Metabolic disorders (1077)
Multiple sclerosis (131)
NASH (21)
Neurodegenerative disease (308)
Neuropsychiatric disorders (82)
Neuroscience (2766)
Neurotech (1)
NextGen: Class of 2026 (3763)
Non-profit (2554)
Now hiring (59)
Obesity (479)
Opinion (180)
Ovarian cancer (161)
Pain (162)
Pancreatic cancer (197)
Parkinson's disease (274)
Partnered (19)
Patents (394)
Patient recruitment (429)
Peanut (52)
People (37167)
Pharmaceutical (49)
Pharmacy benefit managers (14)
Phase 1 (19247)
Phase 2 (26334)
Phase 3 (18698)
Pipeline (4395)
Policy (158)
Postmarket research (1807)
Preclinical (8382)
Press Release (57)
Prostate cancer (202)
Psychedelics (51)
Radiopharmaceuticals (255)
Rare diseases (811)
Real estate (2446)
Recruiting (21)
Regulatory (16265)
Reports (21)
Research institute (1790)
Resumes & cover letters (119)
Rett syndrome (27)
RNA editing (21)
RSV (55)
Schizophrenia (140)
Series A (205)
Series B (159)
Service/supplier (5)
Sickle cell disease (89)
Special edition (18)
Spinal muscular atrophy (149)
Sponsored (28)
Startups (2523)
State (1)
Stomach cancer (13)
Supply chain (55)
Tariffs (28)
The Weekly (72)
Vaccines (725)
Venture capital (77)
Weight loss (279)
Women's health (51)
Worklife (5)
Date
Today (136)
Last 7 days (435)
Last 30 days (1554)
Last 365 days (23628)
2026 (2525)
2025 (23821)
2024 (27345)
2023 (30379)
2022 (37576)
2021 (39975)
2020 (36057)
2019 (28493)
2018 (21340)
2017 (21518)
2016 (19853)
2015 (23591)
2014 (17267)
2013 (13523)
2012 (14078)
2011 (14532)
2010 (13342)
Location
Africa (350)
Alabama (71)
Alaska (3)
Arizona (128)
Arkansas (6)
Asia (25972)
Australia (4821)
California (8794)
Canada (2476)
China (933)
Colorado (337)
Connecticut (386)
Delaware (305)
Europe (60193)
Florida (1245)
Georgia (266)
Hawaii (3)
Idaho (34)
Illinois (576)
India (48)
Indiana (311)
Iowa (12)
Japan (355)
Kansas (92)
Kentucky (25)
Louisiana (24)
Maine (40)
Maryland (1044)
Massachusetts (6794)
Michigan (177)
Minnesota (400)
Mississippi (4)
Missouri (71)
Montana (26)
Nebraska (16)
Nevada (70)
New Hampshire (45)
New Jersey (2433)
New Mexico (16)
New York (2313)
North Carolina (1085)
North Dakota (9)
Northern California (4322)
Ohio (227)
Oklahoma (12)
Oregon (31)
Pennsylvania (1742)
Puerto Rico (14)
Rhode Island (28)
South America (492)
South Carolina (20)
South Dakota (1)
Southern California (3458)
Tennessee (107)
Texas (1343)
United States (30866)
Utah (218)
Virginia (192)
Washington D.C. (52)
Washington State (775)
West Virginia (2)
Wisconsin (73)
445,869 Results for "plasma protein therapeutics association".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
PARTNERED WITH VIVA BIOTECH
Building the Next Generation of Biologics: Inside the Future of Protein Engineering
As bispecifics, ADCs, protein degraders, and AI-designed mini-proteins move into the clinic, discovery teams face a new bottleneck: engineering and producing molecules whose complexity challenges conventional workflows.
December 1, 2025
·
9 min read
·
BioSpace Insights
Press Releases
Origami Therapeutics Announces Global Collaboration with Ipsen to Advance Protein Degrader Program
February 2, 2026
·
2 min read
Press Releases
Plasma Protein Therapeutic Market worth US$ 52.82 billion by 2032 with 6.5% CAGR | Coherent Market Insights
June 12, 2025
·
1 min read
Press Releases
Resolve Therapeutics to Present at International Symposium on Circulating Nucleic Acids in Plasma and Serum (CNAPS)
November 18, 2025
·
2 min read
Streck launches Protein Plus BCTTM for stabilization of plasma proteins in whole blood
LaVista, Nebraska – Streck is pleased to announce the launch of Protein Plus BCTTM, a direct draw whole blood collection tube intended for the stabilization of draw-time concentrations of plasma proteins during ambient temperature storage. Protein Plus BCT is For Research Use Only. Not for use in diagnostic procedures.
April 8, 2024
·
1 min read
Press Releases
Zepto Life Technology Launches Plasma-Based FungiFlex® Mold Panel as CLIA Reference Laboratory Test
January 22, 2026
·
2 min read
Press Releases
Accord Plasma B.V. Expands Global Plasma Therapy Capabilities with Acquisition of Prothya Biosolutions
October 20, 2025
·
2 min read
Press Releases
Enodia Therapeutics Secures €20.7M to Advance a Small-Molecule Platform for Targeted Protein Degradation Enabled by Proteomics and Machine Learning
January 9, 2026
·
6 min read
Press Releases
CervoMed Presents New Plasma Biomarker Data That Indicates Neflamapimod Broadly Improves Neuroinflammation and Neurodegeneration in Dementia with Lewy Bodies (DLB)
December 2, 2025
·
11 min read
BioMidwest
LFB Plasma Joins Plasma Protein Therapeutics Association (PPTA)
LFB Plasma, a US-based plasma collection company and subsidiary of the LFB Group, a leading European company providing plasma-derived products to healthcare professionals, announces joining the Plasma Protein Therapeutics Association.
September 9, 2022
·
2 min read
1 of 44,587
Next
